Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group (Q27824835)
scientific article
Language:
(P31) (Q13442814)
(P50) (Q56798835)
(P304) 4265-74
(P407) (Q1860)
(P433) 19
(P478) 23
(P577) Friday, July 1, 2005
(P921) (Q42824440)
(Q181600)
(Q12859063)
(Q412616)
(Q420436)
(P1433) (Q400292)
(P1476) "Randomized phase II trial of the efficacy and safety of trastuzumab combined with docetaxel in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer administered as first-line treatment: the M77001 study group" (language: en)
(P2093) Michel Marty
Francesco Cognetti
Dominique Maraninchi
Ray Snyder
Louis Mauriac
Michèle Tubiana-Hulin
Stephen Chan
Antonio Antón
Ana Lluch
John Kennedy
Kenneth O'Byrne
Michael Green
Carol Ward
Karen Mayne
Jean-Marc Extra
David Grimes
other details
description scientific article

External Links